Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
2.
Antivir Chem Chemother ; 24(5-6): 161-165, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27620888

RESUMO

METHODS: Hep-2 cells were preincubated with DAS181 or control DAS185 (a mutated sialidase) prior to inoculation with human metapneumovirus strains. Infectivity was assessed by a cell-based ELISA quantitating human metapneumovirus matrix protein. The effect of DAS181 on binding of recombinant G attachment protein was also determined. RESULTS: DAS181 blocked infection of human metapneumovirus strains A2, B1, and B2 at low concentrations. No effect of DAS185 was observed. Binding of MPV G protein to Hep-2 cells was also markedly inhibited by preincubation of cells with DAS181. CONCLUSIONS: These results suggest that human metapneumovirus may utilize sialic acids as an entry cofactor. DAS181 may thus represent a new therapeutic agent useful for the treatment of human metapneumovirus.


Assuntos
Infecções por Paramyxoviridae/metabolismo , Proteínas Recombinantes de Fusão/metabolismo , Animais , Linhagem Celular , Glicoproteínas/metabolismo , Humanos , Macaca mulatta , Infecções por Paramyxoviridae/terapia , Replicação Viral/efeitos dos fármacos
5.
J Infect ; 62(5): 388-93, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21420426

RESUMO

OBJECTIVE: The aim of this study was to determine the humoral immune response to influenza A H1N1 2009 and cross reactivity against seasonal H1N1 and H3N2 strains. METHODS: Baseline and convalescent sera from 88 subjects with confirmed H1N1 2009 were screened for serological responses by HAI assay. RESULTS: Protective antibody titres to H1N1 2009 were present in 87% post-infection, but varied with age, sex and pregnancy. Some cross reactivity with seasonal influenza strains was observed. CONCLUSIONS: Females and pregnant subjects had an attenuated immune response to H1N1 2009 in comparison to the rest of the study population. Antibodies from the serum of H1N1 2009 infected subjects cross reacted with seasonal H1N1 and H3N2 influenza viruses.


Assuntos
Anticorpos Antivirais/sangue , Vírus da Influenza A Subtipo H1N1/imunologia , Influenza Humana/imunologia , Influenza Humana/virologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticorpos Antivirais/imunologia , Reações Cruzadas , Feminino , Testes de Inibição da Hemaglutinação , Humanos , Vírus da Influenza A Subtipo H3N2/imunologia , Masculino , Pessoa de Meia-Idade , Gravidez , Complicações Infecciosas na Gravidez/imunologia , Complicações Infecciosas na Gravidez/virologia , Adulto Jovem
6.
Clin Exp Ophthalmol ; 37(8): 806-9, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19878227

RESUMO

A 3-year-old girl from the Northern Territory developed suppurative keratitis after swimming in pools. A mycelial organism suspected to be Pythium insidiosum was cultured. Treatment with polyhexamethylene biguanide and voriconazole for 5 days was unsuccessful, and a corneal graft was performed. The infection was cleared and when last seen 14 months after surgery the patient had a stable graft and useful vision. The identification of the organism was confirmed by rRNA gene sequencing. P. insidiosum is an oomycete, an organism more closely related to kelp than to fungi. Masses of hyphae were seen in sections and, for the first time, the ultrastructure of P. insidiosum in human tissue is described. The staining characteristics of cultured hyphae were assessed; lactofuchsin and acridine orange were found to be the most useful methods. Although the diagnosis of P. insidiosum keratitis is not difficult, and the organism is susceptible in vitro to a number of antimicrobial agents, early corneal transplantation remains the treatment of choice.


Assuntos
Biguanidas/administração & dosagem , Transplante de Córnea , Úlcera da Córnea , Pirimidinas/administração & dosagem , Pythium/isolamento & purificação , Triazóis/administração & dosagem , Antifúngicos/administração & dosagem , Austrália , Pré-Escolar , Úlcera da Córnea/tratamento farmacológico , Úlcera da Córnea/microbiologia , Úlcera da Córnea/cirurgia , Desinfetantes/administração & dosagem , Quimioterapia Combinada , Feminino , Genes de RNAr , Humanos , Pythium/genética , Voriconazol
7.
FASEB J ; 23(3): 731-8, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18971260

RESUMO

The pneumococcal histidine triad (Pht) proteins are a recently recognized family of surface proteins, comprising 4 members: PhtA, PhtB, PhtD, and PhtE. They are being promoted for inclusion in a multicomponent pneumococcal protein vaccine currently under development, but to date, their biological functions and their relative contributions to pathogenesis have not been clarified. In this study, the involvement of these proteins in pneumococcal virulence was investigated in murine models of sepsis and pneumonia by using defined, nonpolar mutants of the respective genes in Streptococcus pneumoniae D39. In either challenge model, mutagenesis of all 4 genes was required to completely abolish virulence relative to the wild-type, suggesting significant functional redundancy among Pht proteins. The in vivo expression of pht genes was significantly up-regulated in the nasopharynx and lungs compared with blood. We provide unequivocal molecular evidence for Zn(2+)-dependent, AdcR-mediated, regulation of pht gene expression by real-time reverse transcriptase-polymerase chain reaction, Western blotting, and electrophoretic mobility-shift assays. We also present the first direct evidence for the biological function of this protein family by demonstrating that Pht proteins are required for inhibition of complement deposition on the pneumococcal surface through the recruitment of complement factor H.


Assuntos
Proteínas de Bactérias/metabolismo , Fator H do Complemento/metabolismo , Hidrolases/metabolismo , Proteínas Repressoras/metabolismo , Streptococcus pneumoniae , Animais , Proteínas de Bactérias/genética , Feminino , Regulação Bacteriana da Expressão Gênica/fisiologia , Hidrolases/genética , Camundongos , Mutação , Pneumonia Pneumocócica/imunologia , Pneumonia Pneumocócica/microbiologia , Ligação Proteica , Proteínas Repressoras/genética , Sepse/imunologia , Sepse/microbiologia , Streptococcus pneumoniae/genética , Streptococcus pneumoniae/metabolismo , Regulação para Cima , Zinco
8.
J Virol ; 82(23): 11767-74, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18786997

RESUMO

Human metapneumovirus (hMPV) is an important cause of lower respiratory tract disease, particularly in infants and young children. hMPV has two major glycoproteins, G and F, which are responsible for virus attachment and membrane fusion, respectively. We investigated the role of cellular glycosaminoglycans (GAGs) and G protein in hMPV infection. The pretreatment of hMPV with soluble heparin markedly inhibited the infection of HEp-2 cells. Recombinant G protein, comprising the extracellular domain of G, bound to heparin-agarose columns and also to HEp-2 cells. hMPV infection and G protein binding to HEp-2 cells was inhibited by other soluble GAGs, including chondroitin sulfates, by the enzymatic removal of cell surface GAGs with GAG lyases or by the pretreatment of cells with basic fibroblast growth factor. The role of cellular GAGs was confirmed by the binding of G protein to wild-type CHO cells but not to GAG-deficient CHO-pgsA745 cells. An analysis of the G protein sequence revealed two adjacent clusters of positively charged amino acids ((149)EKKKTRA(155) and (159)QRRGKGKE(166)). Truncated G fragments were expressed, and only the fragment containing these putative heparin binding domains retained heparin binding. The alanine mutagenesis of charged residues in either of these regions resulted in the loss of binding to heparin and to HEp-2 cells, suggesting that both sites are likely to be required for hMPV attachment. These results, taken together with the inhibition of hMPV infection by soluble G protein, indicate an important role for G protein and cellular GAGs in hMPV infection.


Assuntos
Glicosaminoglicanos/fisiologia , Metapneumovirus , Infecções por Paramyxoviridae/etiologia , Proteínas do Envelope Viral/fisiologia , Animais , Sulfato de Dextrana/farmacologia , Heparina/metabolismo , Heparina/farmacologia , Humanos , Ácido Idurônico/farmacologia , Macaca mulatta , Ligação Proteica
9.
Mol Immunol ; 43(10): 1624-32, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16263173

RESUMO

Complement factor H (fH) plays a pivotal role in regulating the alternative pathway, allowing complement activation to proceed on foreign surfaces, whilst protecting surrounding host cell surfaces from complement-mediated damage. Host cell recognition is mediated by polyanions such as sialic acid and glycosaminoglycans (GAGs), which promote a high affinity interaction between fH and C3b deposited on host cell surfaces. Factor H is composed of 20 short consensus repeats (SCRs); two heparin-binding sites have been identified within SCR 7 and SCR 20 and a third site is thought to exist within or near SCR 13. Using an extensive series of recombinant fH fragments and heparin affinity chromatography, we have localized the third heparin-binding domain to SCR 9. A recombinant fH fragment containing both SCR 7 and SCR 9 exhibited higher affinity for heparin than SCR 7 alone, suggesting that the individual heparin-binding sites interact simultaneously with heparin to create a higher avidity interaction. Recombinant fragments containing SCR 9 bound to endothelial cells, indicating that this domain is capable of interacting with polyanions within a physiologically relevant environment. In addition, the three heparin-binding sites exhibited differences in their specificity for certain GAGs, suggesting that the individual binding domains may possess separate GAG recognition functions.


Assuntos
Heparina/química , Sequência de Aminoácidos , Sítios de Ligação/genética , Fator H do Complemento/química , Fator H do Complemento/genética , Sequência Consenso , Células Endoteliais/química , Humanos , Dados de Sequência Molecular , Estrutura Terciária de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Sequências Repetitivas de Aminoácidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA